• Gene Editing
  • Product Highlights
  • Effective Serratia marcescens Nuclease for DNA & RNA Removal: MaxNuclease™

    Feb 21, 2025

    Nucleic acid removal is an essential step in biologics production workflows. Our MaxNuclease™ enzyme is a non-specific endonuclease from Serratia marcescens. This Benzonase® nuclease alternative offers a quality, cost-effective alternative for degrading both DNA and RNA in biological products. MaxNuclease™ provides comparable performance for nucleic acid digestion and is manufactured in our cGMP facility, making it suitable for commercial or preclinical biologics workflows.

    Enzyme Characteristics

    MaxNuclease™ is identified from Serratia marcescens and is a genetically engineered endonuclease expressed in E. coli (Escherichia coli). The endonuclease is manufactured in a cGMP facility with stringent quality release testing. MaxNuclease™ degrades all forms of nucleic acids including single- and double-stranded, linear and circular nucleic acids by hydrolyzing internal phosphodiester bonds between nucleotides to produce 5'-monophosphate oligonucleotides of 2-5 bases in length.

    Quality Control Criteria

    Assay

    Specification

    Activity (Dissolve herring sperm DNA)

    ≥ 250 U/µL

    Purity (Bis-Tris)

    ≥ 95%

    Purity (SEC-HPLC)

    ≥ 99%

    Residual Protease

    Negative

    Residual Host Protein

    ≤ 10 ppm

    Endotoxin

    ≤ 0.01 EU/kU

    Sterility

    Negative

    Residual Heavy Metal

    ≤ 10 ppm

    Mycoplasma

    Negative

    Product Performance Data

    MaxNuclease™ exhibits comparable degradation activity to leading Serratia marcescens nuclease in host cell DNA removal and plasmid DNA removal. 

    Host Cell DNA Removal

    Virus harvest solution was treated with 25U/mL and 50U/mL endonuclease at 37°C for 2 hours, respectively. Detection of Host Cell DNA (HCD) residue was analyzed. MaxNuclease™ has higher degradation activity versus Competitor B demonstrated by lower HCD residue for both 25U/mL and 50U/mL working concentrations.

    Figure 1. Virus harvest solution was treated with 25U/mL and 50U/mL endonuclease at 37°C for 2 hours, respectively. Detection of Host Cell DNA (HCD) residue was analyzed. MaxNuclease™ has higher degradation activity versus Competitor B demonstrated by lower HCD residue for both 25U/mL and 50U/mL working concentrations.

    Plasmid DNA Removal

    Virus harvest solution was treated with 25U/mL and 50U/mL endonuclease at 37°C for 2 hours, respectively. Detection of plasmid DNA (pDNA) residue was analyzed. MaxNuclease™ has higher degradation activity versus Competitor B demonstrated by lower pDNA residue for both 25U/mL and 50U/mL working concentrations.

    Figure 2. Virus harvest solution was treated with 25U/mL and 50U/mL endonuclease at 37°C for 2 hours, respectively. Detection of plasmid DNA (pDNA) residue was analyzed. MaxNuclease™ has higher degradation activity versus Competitor B demonstrated by lower pDNA residue for both 25U/mL and 50U/mL working concentrations.

    Degradation of PCR Product, Genomic DNA, and Plasmid DNA

    MaxNuclease™ added to PCR product, genomic DNA, and plasmid DNA shows comparable degradation activity of nucleic acids to leading competitors.

    Figure 3. MaxNuclease™ added to PCR product, genomic DNA, and plasmid DNA shows comparable degradation activity of nucleic acids to leading suppliers.

    Applications

    • Biologics Workflows: Remove nucleic acids in industrial biological products such as vaccines, polysaccharides, and recombinant proteins, to meet regulatory requirements and improve product efficacy.

    • Viscosity Reduction: Reduce the viscosity of cell lysates and cell clumping, increasing protein yield, improving separation effect, making it easy to filter (especially ultrafiltration), and facilitate downstream chromatographic purification workflows. 

    • Viral Vector Production: Remove unwanted nucleic acids in gene therapy vector preparations, such as AAV and lentiviral vectors, to avoid aggregation in cell products and improve purification efficiency.

    • Viral Vaccine Production: Reduce host-derived nucleic acids and plasmid DNA during vaccine manufacturing, decreasing viscosity and preventing aggregate formation, to improve downstream processing. 

    • Sample Preparation: Improve resolution and recovery in biochemical analysis such as ELISA, chromatography, two-phase electrophoresis, and footprinting analysis, by degrading nucleic acids in samples.

    Operating Conditions

    MaxNuclease™ has the following optimal and effective reaction conditions: 

    Condition

    Optimal*

    Effective**

    Mg2+

    1-2mM

    1-10mM

    Na+, K+

    0-100mM

    0-300mM

    pH

    8-10

    4-10

    Temperature

    37℃

    0-50℃

    PO43-

    0-10mM

    0-80mM

     

    *The condition under which MaxNuclease™ retains >90% of its activity

    **The condition under which MaxNuclease™ retains >15% of its activity

    Effect of Temperature

    Effect of temperature on MaxNuclease™ activity. The relative activity rises with increasing temperature. The optimum temperature is 37°C-42°C.

    Figure 4. Effect of temperature on MaxNuclease™ activity. The relative activity rises with increasing temperature. The optimum temperature is 37°C-42°C.

    Effect of pH

    Effect of pH on MaxNuclease™ endonuclease activity. The optimum pH is between 8 and 10.

    Figure 5. Effect of pH on MaxNuclease™ endonuclease activity. The optimum pH is between 8 and 10.

    Stability Testing

    Stability of MaxNuclease™ at 37°C and 25°C. The relative activity is stable when stored at 37°C and 25°C for up to 7 days.

    Figure 6. Stability of MaxNuclease™ at 37°C and 25°C. The relative activity is stable when stored at 37°C and 25°C for up to 7 days.

    Freeze-thaw stability of MaxNuclease™. The relative activity is stable when MaxNuclease™ is freeze/thawed between -80°C to 4°C and -20°C to 25°C up to 12 times. 

    Figure 7. Freeze-thaw stability of MaxNuclease™. The relative activity is stable when MaxNuclease™ is freeze/thawed between -80°C to 4°C and -20°C to 25°C up to 12 times. 

    MaxNuclease™ ELISA Kit

    After nucleic acid removal using MaxNuclease™, the residual enzyme in the product or sample must be evaluated. For residual MaxNuclease™ detection, KACTUS has developed a highly sensitive and specific sandwich ELISA quantification kit, with a sensitivity of up to 23 pg/mL.

    Example Standard Curve

    Example 8-point standard curve for MaxNuclease™ ELISA kit to quantify residual MaxNuclease™ enzyme. 

    Figure 7. Example 8-point standard curve for MaxNuclease™ ELISA kit to quantify residual MaxNuclease™ enzyme. 

    Affordable Endonuclease for Biologics Production Small and Large Scale

    MaxNuclease™ is an active and reliable alternative to Benzonase® nuclease for nucleic acid removal in various biologics manufacturing processes. Its high efficiency, cost-effectiveness, and GMP-grade production make it a valuable nuclease for viral vaccine, viral vector, and recombinant protein production workflows. MaxNuclease™ is suitable for small and large-scale production and is available in a consistent, long-term supply. To learn more about MaxNuclease™, please contact us at support@kactusbio.us

    Request a quote or test sample →

    Products

    MaxNuclease™, GMP-Grade

    MaxNuclease™ ELISA Kit

    Additional Resources

    About MaxNuclease™

    Product Brochure

     

    Benzonase® is a registered trademark of Merck KGaA. MaxNuclease™ is a product of KactusBio Inc. 


    More from > Gene Editing Product Highlights